🕵️ LAVA Therapeutics NV ($LVTX)
SEC insider & ownership activity, last 12 months · CIK 1840748 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Nov 21, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, value withheld pending verification (17 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | 0 | – | 8 | value withheld pending verification | Sep 19, 2025 |
| Cooperatieve Gilde Healthcare IV U.A. | 0 | – | 9 | value withheld pending verification | Oct 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| SHAY Capital LLC | 9.9% | 13G | Sep 26, 2025 | filing ↗ | |
| SHAY Capital Holdings LLC | 9.9% | 13G | Sep 26, 2025 | filing ↗ | |
| BML Investment Partners, L.P. | 7.4% | 13G | Mar 3, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Nov 21, 2025 | filing ↗ |
| Delisting notice (3.01) | Nov 21, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Nov 21, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 21, 2025 | filing ↗ |
| Delisting notice (3.01) | Nov 12, 2025 | filing ↗ |
| Change of control (5.01) | Nov 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 7, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Oct 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Oct 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 2, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |